Pulmonary Hypertension Association's 2022 International Conference Scientific Sessions Overview

• Published in: Pulmonary circulation Vol. 13; no. 1; pp. e12182 - n/a
• Main Authors: Alamri, Ayedh K., Shelburne, Nicholas J., Mayeux, Jennalyn D., Brittain, Evan
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01-01-2023; John Wiley and Sons Inc; Wiley
• Subjects: Clinical outcomes; Clinical Trials as topic; Combination therapy; Conference Report; Epigenetics; Hemodynamics; Lung transplants; Mortality; Pulmonary arteries; Pulmonary hypertension; Pulmonary Hypertension Association; Quality of life; registries; Senescence; United States > US; registries; Pulmonary Hypertension Association; pulmonary hypertension; Clinical Trials as topic
• ISSN: 2045-8940; 2045-8932; 2045-8940
• DOI: 10.1002/pul2.12182

The considerable progress made in recent years in the diagnosis, risk stratification, and treatment of pulmonary hypertension was highlighted during the most recent edition of the Pulmonary Hypertension Association Scientific Sessions, which was held in Atlanta, Georgia from June 9 to 11, 2022, with the theme: Vision for the PHuture: The Evolving Science and Management of PH. Content presented over the 3‐day conference focused on scientific and management updates since the last sessions were held in 2018 and included didactic talks, debates, and roundtable discussions across a broad spectrum of topics related to pulmonary hypertension. This article aims to summarize the key messages from each of the session talks.